Clinical Trial Update: A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008) [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical study of MK-1045 for non-Hodgkin lymphoma, including follicular lymphoma and diffuse large B-cell lymphoma, with recruitment not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• MK-1045

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Lymphoma, Non-Hodgkin, Lymphoma, Follicular | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING